Gainers
- Nutriband NTRB shares moved upwards by 28.0% to $6.67 during Wednesday's pre-market session. The market value of their outstanding shares is at $74.0 million.
- Predictive Oncology POAI stock moved upwards by 22.83% to $1.56. The company's market cap stands at $10.4 million.
- Metagenomi MGX shares rose 21.32% to $3.3. The company's market cap stands at $123.4 million.
- Gelteq GELS shares rose 18.09% to $2.48. The market value of their outstanding shares is at $23.4 million.
- Evaxion Biotech EVAX stock rose 12.91% to $3.06. The market value of their outstanding shares is at $17.9 million.
- Cardio Diagnostics Hldgs CDIO stock moved upwards by 12.48% to $0.68. The company's market cap stands at $27.6 million.
Losers
- Hepion Pharmaceuticals HEPA stock decreased by 59.0% to $0.13 during Wednesday's pre-market session.
- Lisata Therapeutics LSTA stock fell 32.83% to $2.62. The company's market cap stands at $21.9 million.
- Xilio Therapeutics XLO shares fell 22.84% to $0.98. The market value of their outstanding shares is at $44.8 million.
- Helius Medical Tech HSDT stock decreased by 19.42% to $0.83. The market value of their outstanding shares is at $3.0 million.
- Dogwood Therapeutics DWTX stock decreased by 12.39% to $2.76. The market value of their outstanding shares is at $3.6 million.
- Dermata Therapeutics DRMA shares decreased by 11.82% to $1.12. The company's market cap stands at $2.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
DRMADermata Therapeutics Inc
$1.03-18.9%
DWTXDogwood Therapeutics Inc
$2.81-10.8%
EVAXEvaxion Biotech AS
$2.40-11.4%
GELSGelteq Ltd
$2.6023.8%
HEPAHepion Pharmaceuticals Inc
$0.1355-57.9%
HSDTHelius Medical Technologies Inc
$0.8117-21.2%
LSTALisata Therapeutics Inc
$2.65-32.0%
MGXMetagenomi Inc
$2.989.56%
NTRBNutriband Inc
$7.3541.1%
POAIPredictive Oncology Inc
$1.4917.3%
XLOXilio Therapeutics Inc
$0.8802-30.7%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in